Eyenovia (EYEN) News Today $0.10 -0.24 (-70.20%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Eyenovia downgraded to Hold from Buy at BrooklineNovember 15 at 8:51 PM | markets.businessinsider.comEyenovia downgraded to Market Perform from Outperform at William BlairNovember 15 at 8:51 PM | markets.businessinsider.comEyenovia to Cut 50% of Workforce After Phase 3 Study DisappointsNovember 15 at 8:51 PM | marketwatch.comEyenovia to End Eye Drug Study, Cut 50% of Its WorkforceNovember 15 at 8:51 PM | money.usnews.comEyenovia Mulls Options After Phase 3 Study FailureNovember 15 at 3:49 PM | marketwatch.comEyenovia plans to terminate Phase 3 CHAPERONE study after DRC reviewNovember 15 at 3:49 PM | markets.businessinsider.comEyenovia Shares Plumb New Depths After Study FailureNovember 15 at 3:49 PM | marketwatch.comEyenovia Third Quarter 2024 Earnings: Misses ExpectationsNovember 15 at 3:49 PM | finance.yahoo.comEyenovia to end eye drug study after missing late-stage goal, shares fallNovember 15 at 3:49 PM | msn.comEyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From PipelineNovember 15 at 2:08 PM | benzinga.comEyenovia to discontinue late-stage study for eye drugNovember 15 at 7:07 AM | reuters.comEyenovia Provides Update on Phase 3 CHAPERONE StudyNovember 15 at 7:00 AM | globenewswire.comHC Wainwright Reiterates "Buy" Rating for Eyenovia (NASDAQ:EYEN)November 15 at 2:43 AM | americanbankingnews.comEyenovia price target lowered to $4.50 from $7 at LadenburgNovember 13, 2024 | markets.businessinsider.comEyenovia’s Strategic Advances and Q3 FinancialsNovember 13, 2024 | markets.businessinsider.comEyenovia’s Promising Growth Prospects: Buy Rating Affirmed by AnalystNovember 13, 2024 | markets.businessinsider.comEyenovia Inc (EYEN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesNovember 13, 2024 | finance.yahoo.comEyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 13, 2024 | markets.businessinsider.comEyenovia, Inc. (EYEN) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comEarnings Outlook For EyenoviaNovember 12, 2024 | benzinga.comEyenovia (EYEN) Scheduled to Post Earnings on TuesdayNovember 10, 2024 | americanbankingnews.comEyenovia to Report Third Quarter 2024 Results on Tuesday, November 12thNovember 7, 2024 | globenewswire.comEyenovia announces publication of study on Optejet, presentationOctober 24, 2024 | markets.businessinsider.comEyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet®October 23, 2024 | finance.yahoo.comEyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 ExpoOctober 16, 2024 | finance.yahoo.comEyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 ExpoOctober 16, 2024 | globenewswire.comEyenovia Inc (EYEN) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesOctober 9, 2024 | finance.yahoo.comEyenovia Inc.October 4, 2024 | wsj.comEyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet DeviceOctober 1, 2024 | markets.businessinsider.comEyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet DeviceOctober 1, 2024 | globenewswire.comEyenovia, Inc. Announces Pricing of $4 Million Registered Direct OfferingSeptember 27, 2024 | globenewswire.comEyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular SurgerySeptember 26, 2024 | globenewswire.comEYEN Shares Are Trading Higher Today: What You Need To KnowSeptember 9, 2024 | msn.comFormosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for CommercializationSeptember 9, 2024 | prnewswire.comEyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.September 5, 2024 | globenewswire.comEyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial OfficerSeptember 3, 2024 | globenewswire.comEyenovia, Inc. (NASDAQ:EYEN) CEO Michael M. Rowe Buys 27,071 SharesAugust 29, 2024 | insidertrades.comEyenovia, Inc. (NASDAQ:EYEN) CEO Michael M. Rowe Buys 50,000 SharesAugust 28, 2024 | insidertrades.comEyenovia Announces Closing of Public OfferingAugust 23, 2024 | globenewswire.comWhy Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?August 22, 2024 | benzinga.comEyenovia Prices 12.85 Mln Shares At $0.40/Share; Stock TanksAugust 21, 2024 | markets.businessinsider.comWhy Eyenovia (EYEN) Stock Is Getting Hammered TodayAugust 21, 2024 | msn.comEyenovia Announces Pricing of $5.14 Million Public OfferingAugust 21, 2024 | globenewswire.comEyenovia, Inc. Announces Proposed Public OfferingAugust 20, 2024 | globenewswire.comEyenovia, Inc. (EYEN) Latest Stock News & Headlines - Yahoo FinanceAugust 16, 2024 | ca.finance.yahoo.comEyenovia, Inc.: Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 15, 2024 | finanznachrichten.deEyenovia, Inc. (NASDAQ:EYEN) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | msn.comEyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceAugust 14, 2024 | finance.yahoo.comEyenovia, Inc. (EYEN) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | seekingalpha.comEYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q2 2024August 12, 2024 | investorplace.com Get Eyenovia News Delivered to You Automatically Sign up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Strange: Why is Amazon suddenly yielding 39.70%? (Ad)Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%! Click here to see this breakthrough before everyone else → EYEN Media Mentions By Week EYEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EYEN News Sentiment▼0.260.56▲Average Medical News Sentiment EYEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EYEN Articles This Week▼302▲EYEN Articles Average Week Get Eyenovia News Delivered to You Automatically Sign up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MRKR News Today VXRT News Today TELO News Today IPSC News Today PDSB News Today DERM News Today ADAG News Today ANRO News Today IVVD News Today ELYM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EYEN) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eyenovia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eyenovia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.